Targeted (hypothesis-driven) sequencing of known DSD genes following meaningful clinical and hormonal assessment (e.g., CYP21A2, CYP11B1, SRD5A2, HSD17B3, AR and others) (30). The gene discussed is SRD5A2; the disease is disorder of sexual differentiation.